» Articles » PMID: 29911518

Biopsychosocial Distress and Clinical Outcome in Metastatic Renal Cell Carcinoma

Overview
Date 2018 Jun 19
PMID 29911518
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Limited research exists examining the biopsychosocial experience of patients diagnosed with metastatic renal cell carcinoma (mRCC), a disease commonly associated with a poor prognosis. The purpose of this study was to describe rates and types of distress in mRCC patients and explore the relationship between distress and overall survival.

Method: A cohort of 102 patients with mRCC treated at a single institution was assessed by a touch screen-based instrument comprising 22 core items spanning physical, practical, functional, and emotional domains. Association between biopsychosocial distress and clinicopathologic criteria was interrogated. Overall survival was compared between patients with low distress versus high distress.ResultHigh rates of distress (20.7%) were found among patients newly diagnosed with mRCC. Among those domains contributing to distress, pain, fatigue, and financial comorbidity were the most commonly reported by patients with mRCC. A trend toward poorer overall survival in those patients with high distress versus low distress was observed among mRCC patients.Significance of resultsBased on data from a relatively large sample of patients, this study provides the first specific insights into the potential impact of biopsychosocial distress and outcomes among patients with mRCC.

Citing Articles

Effective symptom relief through continuous integration of palliative care in advanced renal cell carcinoma patients: comprehensive measurement using the palliative care base assessment.

Dorr A, Vogel I, Wittenbecher F, Westermann J, Thuss-Patience P, Ahn J Palliat Care Soc Pract. 2024; 18:26323524241260424.

PMID: 39045295 PMC: 11265252. DOI: 10.1177/26323524241260424.


Psychosocial distress after radical prostatectomy, radical cystectomy, or (partial) nephrectomy - a comprehensive analysis of 4,290 German cancer patients during the COVID-19 pandemic.

Bahlburg H, Rausch P, Tully K, Berg S, Noldus J, Butea-Bocu M J Cancer Surviv. 2024; .

PMID: 38985430 DOI: 10.1007/s11764-024-01644-w.


Patient's self-reported quality of life as a prognostic factor in metastatic renal cell carcinoma initially treated with TKI: nomogram proposal.

Lendinez-Cano G, Vilches-Arenas A, Congregado-Ruiz B, Medina-Lopez R World J Urol. 2024; 42(1):267.

PMID: 38678165 DOI: 10.1007/s00345-024-04972-9.


Exploring the Therapeutic Significance of microRNAs and lncRNAs in Kidney Diseases.

Bravo-Vazquez L, Paul S, Colin-Jurado M, Marquez-Gallardo L, Castanon-Cortes L, Banerjee A Genes (Basel). 2024; 15(1).

PMID: 38275604 PMC: 10815231. DOI: 10.3390/genes15010123.


Psychological Distress in Patients Treated for Renal Cell Carcinoma: A Systematic Literature Review.

Vartolomei L, Schmidinger M, Vartolomei M, Shariat S J Clin Med. 2022; 11(21).

PMID: 36362610 PMC: 9657659. DOI: 10.3390/jcm11216383.